| Name | Trandolaprilat Monohydrate |
|---|---|
| Synonyms |
(2S,3,7aS)-1-[(2S)-2-[[(1S)-1-cboxy-3-phenylpropyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-cboxylic acid
Trandolaprilate Monohydrate RU 44403 hydrate|||RU 44403 hydrate|||Trandolaprilat hydrate (2S,3,7aS)-1-[N-[(S)-1-Cboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecboxylic Acid Monohydrate (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid, hydrate Trandolaprilat (hydrate) Trandolaprilate hydrate |
| Description | Trandolaprilate hydrate is a potent angiotensin-converting enzyme (ACE) inhibitor. Trandolaprilate hydrate partially inhibits angiotensin-I-mediated c-fos induction. Trandolaprilate is main bioactive metabolite of Trandolapril. Trandolaprilate shows high lipophilicity[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Molecular Formula | C22H32N2O6 |
|---|---|
| Molecular Weight | 420.49900 |
| Exact Mass | 420.22600 |
| PSA | 116.17000 |
| LogP | 2.55930 |